Translational Software
Request a demo
Resources

Publications by
Translational Software alumni.

Peer-reviewed papers, posters, and chapters co-authored by current and former employees of Translational Software.

  1. Miller BA, Savieo JL, Tucker JP, Hachad H, Levy RH, Ragueneau-Majlessi I. Projected Incidence of Underrepresented Variants in CYP2C9 Testing Regarding Warfarin. Poster presented at Pharmacogenomics Research Network Pharmacogenomics Poster Session and Reception at ASHG 2019; 2019 Oct 17; Houston, TX.Poster
  2. Hachad H, Joshi AD. Comedication-Induced Phenoconversion: Prevalence of Phenotypic CYP2D6 Poor Metabolizers Among Genetically Tested Patients. Poster presented at UF Precision Medicine Conference Poster Session; 2018 Mar; Orlando, FL.Poster
  3. Joshi AD, Munir J, Wong JJ, Hachad H. Large Scale Implementation of Clinical Pharmacogenomics: A Perspective from Using a Clinical Decision Support Tool. Poster presented at Individualized Medicine Conference Poster Session; 2017 Oct; Rochester, MN.Poster
  4. Joshi AD, Munir J, Wong JJ, Hachad H. High Prevalence of Drug-Gene Interactions in Patients Taking Commonly Prescribed Medications. Poster presented at Pharmacogenomics Research Network Pharmacogenomics Poster Session and Reception at ASHG 2017; 2017 Oct; Orlando, FL.Poster
  5. Hachad H, Joshi AD, Xie Y, Rule D. Prioritizing Individuals and Patient Populations for Clinical Pharmacogenomics Testing. Poster presented at UF Precision Medicine Conference Poster Session; 2017 Oct 4-7; Orlando, FL.Poster
  6. Joshi AD, Munir J, Hachad H, Rule D. Insights from a Large-Scale Pharmacogenomics Implementation Platform. Poster presented at UF Precision Medicine Conference Poster Session; 2017 Mar 9; Orlando, FL.Poster
  7. Frear S, Sherman A, Rule D, Marcath LA. Prevalence of CYP2D6 structural variation in large retrospective study. Pharmacogenet Genomics. 2024 Jun 1;34(4):135-138. [PubMed]
  8. Gill PS, Yu FB, Porter-Gill PA, Boyanton BL, Allen JC, Farrar JE, Veerapandiyan A, Prodhan P, Bielamowicz KJ, Sellars E, Burrow A, Kennedy JL, Clothier JL, Becton DL, Rule D, Schaefer GB. Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital. J Pers Med. 2021 May 11;11(5):394. [PubMed]
  9. Nofziger C, Turner AJ, Sangkuhl K, Whirl-Carrillo M, Agúndez JAG, Black JL, Dunnenberger HM, Ruano G, Kennedy MA, Phillips MS, Hachad H, Klein TE, Gaedigk A. PharmVar GeneReview: CYP2D6. Clin Pharmacol Ther. 2019 Sep 22. [PubMed]
  10. Pratt VM, Cavallari LH, Del Tredici AL, Hachad H, Ji Y, Moyer AM, Scott SA, Whirl-Carrillo M, Weck KE. Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn. 2019 Sep;21(5):746-755. [PubMed]
  11. Hachad H, Ramsey LB, Scott SA. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers. Clin Pharmacol Ther. 2019 Aug;106(2):298-301. [PubMed]
  12. Thorn CF, Whirl-Carrillo M, Hachad H, Johnson JA, McDonagh EM, Ratain MJ, Relling MV, Scott SA, Altman RB, Klein TE. Essential Characteristics of Pharmacogenomics Study Publications. Clin Pharmacol Ther. 2019 Jan;105(1):86-91. [PubMed]
  13. Pratt VM, Del Tredici AL, Hachad H, Ji Y, Kalman LV, Scott SA, Weck KE. Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology. J Mol Diagn. 2018 May;20(3):269-276. [PubMed]